Sanger, Illumina Team Sequences Tasmanian Devil Genome | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Researchers from the Wellcome Trust Sanger Institute and Illumina announced that they have sequenced a draft version of the Tasmanian devil genome as well as a pair of cancer genomes from animals with Tasmanian devil facial tumor disease, a transmissible cancer plaguing wild devils.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.